董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Jeffrey A. Bailey | 男 | Director | 54 | 16.00万 | 未持股 | 2017-01-12 |
| Teri G. Fontenot | 女 | Director | 63 | 4.48万 | 未持股 | 2017-01-12 |
| Michael P. Kaminski | 男 | Director,President and Chief Executive Officer | 56 | 155.84万 | 未持股 | 2017-01-12 |
| Jeffrey A. Strong | 男 | Director | 39 | 未披露 | 未持股 | 2017-01-12 |
| David E. Meador | 男 | Director | 59 | 17.80万 | 未持股 | 2017-01-12 |
| Robert J. Cronin | 男 | Director | 81 | 18.50万 | 未持股 | 2017-01-12 |
| Michael T. Leatherman | 男 | Executive Chairman of the Board | 63 | 54.34万 | 未持股 | 2017-01-12 |
| Stephen C. Mitchell | 男 | Director | 73 | 17.20万 | 未持股 | 2017-01-12 |
| Thomas M. White | 男 | Director | 59 | 16.00万 | 未持股 | 2017-01-12 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Daniel J. Fujii | 男 | Vice President, Chief Financial Officer and Secretary | 42 | 72.28万 | 未持股 | 2017-01-12 |
| G. Douglas King | 男 | Senior Vice President, Administration and Chief Information Officer | 49 | 67.10万 | 未持股 | 2017-01-12 |
| Michael P. Kaminski | 男 | Director,President and Chief Executive Officer | 56 | 155.84万 | 未持股 | 2017-01-12 |
| Michael T. Leatherman | 男 | Executive Chairman of the Board | 63 | 54.34万 | 未持股 | 2017-01-12 |
| William G. Dempsey | 男 | Lead Director of the Board | 65 | 17.20万 | 未持股 | 2017-01-12 |
| Michael R. Kennedy | 男 | Senior Vice President, Strategic Marketing and Product Development | 58 | 67.46万 | 未持股 | 2017-01-12 |
董事简历
中英对照 | 中文 | 英文- Jeffrey A. Bailey
-
Jeffrey A. Bailey，他一直担任董事（2015年4月以来）。2013年1月至2015年9月，他曾担任Lantheus Medical Imaging公司（主要用于心血管疾病诊断的诊断显像剂的全球领导人）的总裁兼首席执行官，以及董事。从2011年8月到2012年12月，他曾担任Fougera Pharmaceuticals公司（原为Nycomed US，公司开发、生产和销售专业局部和皮肤病的药物）的首席运营官。2010年8月至2011年7月，他曾担任King-Pfizer Pharmaceuticals公司（多样化的专业医药发现和临床开发公司）的首席商业官。从2008年到2010年，他曾担任Novartis NorthWest Operating Unit的总裁兼总经理。1984年至2006年，他曾担任the Johnson & Johnson集团公司的多种执行、商业和制造职务。他目前任职于审计和薪酬委员会。
Jeffrey A. Bailey has been a director since April 2015. Mr. Bailey currently serves as Chairmen and CEO of Neurovance, Inc. that develops innovative new Neurology therapies. He has served as Neurovance Chairmen since January 2016 and CEO since November 2016. From January 2013 through September 2015 Mr. Bailey served as President and Chief Executive Officer and a Director of Lantheus Medical Imaging, Inc., a global leader in providing diagnostic imaging agents, primarily used for the diagnosis of cardiovascular diseases. From August 2011 to December 2012 Mr. Bailey was Chief Operating Officer of Fougera Pharmaceuticals formerly Nycomed US, a company that develops, manufactures and markets specialty topical and dermatology medicines. From August 2010 to July 2011 he was Chief Commercial Officer of King-Pfizer Pharmaceuticals, a diversified specialty pharmaceutical discovery and clinical development company, and from 2008 to 2010 Mr. Bailey was President and General Manager of a Novartis Operating Unit. From 1984 to 2006 Mr. Bailey held various executive, commercial and manufacturing roles within the Johnson & Johnson family of companies. Mr. Bailey serves on the Audit and Compensation Committees. - Jeffrey A. Bailey，他一直担任董事（2015年4月以来）。2013年1月至2015年9月，他曾担任Lantheus Medical Imaging公司（主要用于心血管疾病诊断的诊断显像剂的全球领导人）的总裁兼首席执行官，以及董事。从2011年8月到2012年12月，他曾担任Fougera Pharmaceuticals公司（原为Nycomed US，公司开发、生产和销售专业局部和皮肤病的药物）的首席运营官。2010年8月至2011年7月，他曾担任King-Pfizer Pharmaceuticals公司（多样化的专业医药发现和临床开发公司）的首席商业官。从2008年到2010年，他曾担任Novartis NorthWest Operating Unit的总裁兼总经理。1984年至2006年，他曾担任the Johnson & Johnson集团公司的多种执行、商业和制造职务。他目前任职于审计和薪酬委员会。
- Jeffrey A. Bailey has been a director since April 2015. Mr. Bailey currently serves as Chairmen and CEO of Neurovance, Inc. that develops innovative new Neurology therapies. He has served as Neurovance Chairmen since January 2016 and CEO since November 2016. From January 2013 through September 2015 Mr. Bailey served as President and Chief Executive Officer and a Director of Lantheus Medical Imaging, Inc., a global leader in providing diagnostic imaging agents, primarily used for the diagnosis of cardiovascular diseases. From August 2011 to December 2012 Mr. Bailey was Chief Operating Officer of Fougera Pharmaceuticals formerly Nycomed US, a company that develops, manufactures and markets specialty topical and dermatology medicines. From August 2010 to July 2011 he was Chief Commercial Officer of King-Pfizer Pharmaceuticals, a diversified specialty pharmaceutical discovery and clinical development company, and from 2008 to 2010 Mr. Bailey was President and General Manager of a Novartis Operating Unit. From 1984 to 2006 Mr. Bailey held various executive, commercial and manufacturing roles within the Johnson & Johnson family of companies. Mr. Bailey serves on the Audit and Compensation Committees.
- Teri G. Fontenot
-
Teri G. Fontenot，加入Bitcoin Depot， Inc.的董事会。2024年7月1日。她是审计委员会主席。在过去的30年里，她曾在许多董事会任职，包括上市公司、大型非营利组织、私人和政府组织。她目前是上市公司Amerisafe （AMSF/审计、治理和风险委员会）和AMN （AMN/审计委员会主席）的董事会成员。她也是Orlando Health， Inc.（一家价值140亿美元的多州健康系统和一家私人公用事业公司）的董事会成员。泰瑞在女子医院担任总裁兼首席执行官长达24年，于2019年3月离职。在她的领导下，卫生系统成为美国最大的独立拥有的妇女和婴儿医院。Teri拥有美国MS大学会计学工商管理硕士学位，东北洛杉矶大学工商管理硕士学位，是一名注册会计师（非活跃）。她也是美国证券交易委员会合格的金融专家。
Teri G. Fontenot,joined the board of directors of Bitcoin Depot, Inc. July 1, 2024. She is the Chair of the Audit Committee. Teri has served on numerous boards over the past 30 years including publicly traded, large not-for-profit, private and governmental organizations. She is currently on the boards of publicly traded companies Amerisafe (AMSF/Audit, Governance and Risk committees) and AMN (AMN/chair of Audit Committee). She is also on the board of Orlando Health, Inc., a $14 billion health multistate health system, and a private utility company. Teri was the president and CEO of Woman's Hospital for 24 years, departing in March 2019. Under her leadership, the health system became the largest independently owned hospital for women and infants in the US. Teri holds a BBA in Accountancy from the University of MS, a MBA from Northeast LA University, and is a certified public accountant (inactive). She is also a SEC-qualified financial expert. - Teri G. Fontenot，加入Bitcoin Depot， Inc.的董事会。2024年7月1日。她是审计委员会主席。在过去的30年里，她曾在许多董事会任职，包括上市公司、大型非营利组织、私人和政府组织。她目前是上市公司Amerisafe （AMSF/审计、治理和风险委员会）和AMN （AMN/审计委员会主席）的董事会成员。她也是Orlando Health， Inc.（一家价值140亿美元的多州健康系统和一家私人公用事业公司）的董事会成员。泰瑞在女子医院担任总裁兼首席执行官长达24年，于2019年3月离职。在她的领导下，卫生系统成为美国最大的独立拥有的妇女和婴儿医院。Teri拥有美国MS大学会计学工商管理硕士学位，东北洛杉矶大学工商管理硕士学位，是一名注册会计师（非活跃）。她也是美国证券交易委员会合格的金融专家。
- Teri G. Fontenot,joined the board of directors of Bitcoin Depot, Inc. July 1, 2024. She is the Chair of the Audit Committee. Teri has served on numerous boards over the past 30 years including publicly traded, large not-for-profit, private and governmental organizations. She is currently on the boards of publicly traded companies Amerisafe (AMSF/Audit, Governance and Risk committees) and AMN (AMN/chair of Audit Committee). She is also on the board of Orlando Health, Inc., a $14 billion health multistate health system, and a private utility company. Teri was the president and CEO of Woman's Hospital for 24 years, departing in March 2019. Under her leadership, the health system became the largest independently owned hospital for women and infants in the US. Teri holds a BBA in Accountancy from the University of MS, a MBA from Northeast LA University, and is a certified public accountant (inactive). She is also a SEC-qualified financial expert.
- Michael P. Kaminski
-
Michael P. Kaminski被任命为首席执行官，于2009年1月1日生效，并仍然持有总裁的头衔，之前自2007年2月以来担任我们的总裁兼首席运营官。他之前担任我们的首席运营官（自2002年4月他加入公司以来）。在加入公司之前，他在Hill-Rom Company Hillenbrand Industries工作近20年。在Hill-Rom担任的最后职位是北美销售和服务的高级副总裁。在此之前，他担任Hill-Rom急症护理医院部门的总经理。他获得泽维尔大学（Xavier University）的工商管理硕士学位，印第安纳大学（Indiana University）市场营销学士学位。作为我们的首席执行官，他在范围广泛的问题上（包括战略规划、项目实施、营销以及投资者关系和金融社区）向董事会提供了全面的洞察力。他告知董事会，他将从公司辞职，于2013年4月12日生效。
Michael P. Kaminski has been the Company’s President and Chief Executive Officer, and a member of the Board of Directors, since October 2015. Mr. Kaminski joined the Company in April 2013 as President, Radiation Measurement. He was President and Chief Executive Officer of Stereotaxis, Inc., a healthcare technology company specializing in the development of robotic cardiology instrument navigation systems, since 2009 and held other senior positions there since 2002. Prior to joining Stereotaxis, Mr. Kaminski spent nearly 20 years with Hill-Rom Company Hillenbrand Industries, where he held several senior level positions. Mr. Kaminski earned a Bachelor of Science in marketing from Indiana University and an MBA from Xavier University. - Michael P. Kaminski被任命为首席执行官，于2009年1月1日生效，并仍然持有总裁的头衔，之前自2007年2月以来担任我们的总裁兼首席运营官。他之前担任我们的首席运营官（自2002年4月他加入公司以来）。在加入公司之前，他在Hill-Rom Company Hillenbrand Industries工作近20年。在Hill-Rom担任的最后职位是北美销售和服务的高级副总裁。在此之前，他担任Hill-Rom急症护理医院部门的总经理。他获得泽维尔大学（Xavier University）的工商管理硕士学位，印第安纳大学（Indiana University）市场营销学士学位。作为我们的首席执行官，他在范围广泛的问题上（包括战略规划、项目实施、营销以及投资者关系和金融社区）向董事会提供了全面的洞察力。他告知董事会，他将从公司辞职，于2013年4月12日生效。
- Michael P. Kaminski has been the Company’s President and Chief Executive Officer, and a member of the Board of Directors, since October 2015. Mr. Kaminski joined the Company in April 2013 as President, Radiation Measurement. He was President and Chief Executive Officer of Stereotaxis, Inc., a healthcare technology company specializing in the development of robotic cardiology instrument navigation systems, since 2009 and held other senior positions there since 2002. Prior to joining Stereotaxis, Mr. Kaminski spent nearly 20 years with Hill-Rom Company Hillenbrand Industries, where he held several senior level positions. Mr. Kaminski earned a Bachelor of Science in marketing from Indiana University and an MBA from Xavier University.
- Jeffrey A. Strong
-
Jeffrey A. Strong，自2005年起担任QVT Financial LP的高级投资专家，主要关注全球特殊状况；2001年至2005年间担任Shenkman Capital Manment的分析师，关注化学、电信、医疗保健行业的高产出投资。他目前是Treveria plc和MCS Holdings LTD的董事。他获得了the College of William & Mary的工商管理硕士学位，和the University of Missouri的学士学位，是一名特许金融分析师。
Jeffrey A. Strong has been a director since January 10 2017. Mr. Strong has served as Chief Investment Officer and Managing Partner of Gilead Capital since January 2016 and as the Managing Member of Gilead Capital GP since September 2014. Prior to joining Gilead Capital GP, Mr. Strong was a Partner at QVT Financial LP, a multi-strategy hedge fund, from 2009 until September 2014 and a Senior Analyst from 2005 to 2009. At QVT, Mr. Strong specialized in active ownership investments and other global special situations. From 2001 to 2005 Mr. Strong served as an Analyst at Shenkman Capital Management, a high-yield bond investment manager, where he focused on the healthcare, chemical, and telecom industries. Mr. Strong is a CFA® charterholder and has an MBA. Mr. Strong serves on the Compensation Committee. - Jeffrey A. Strong，自2005年起担任QVT Financial LP的高级投资专家，主要关注全球特殊状况；2001年至2005年间担任Shenkman Capital Manment的分析师，关注化学、电信、医疗保健行业的高产出投资。他目前是Treveria plc和MCS Holdings LTD的董事。他获得了the College of William & Mary的工商管理硕士学位，和the University of Missouri的学士学位，是一名特许金融分析师。
- Jeffrey A. Strong has been a director since January 10 2017. Mr. Strong has served as Chief Investment Officer and Managing Partner of Gilead Capital since January 2016 and as the Managing Member of Gilead Capital GP since September 2014. Prior to joining Gilead Capital GP, Mr. Strong was a Partner at QVT Financial LP, a multi-strategy hedge fund, from 2009 until September 2014 and a Senior Analyst from 2005 to 2009. At QVT, Mr. Strong specialized in active ownership investments and other global special situations. From 2001 to 2005 Mr. Strong served as an Analyst at Shenkman Capital Management, a high-yield bond investment manager, where he focused on the healthcare, chemical, and telecom industries. Mr. Strong is a CFA® charterholder and has an MBA. Mr. Strong serves on the Compensation Committee.
- David E. Meador
-
David E. Meador，2001年起担任DTE能源执行副总裁和CFO。1997-2001年担任DTE能源副总裁和财务总管。DTE能源为密歇根企业和家庭提供安全可靠的电力和天然气服务，其能源相关业务和服务遍及全国。1983-1997年曾担任克莱斯勒汽车公司各种财务和会计职位。他的专业生涯开始于Coopers和Lybrand，并且是一位注册会计师。他担任能源公司高管的经历为核电行业提供了重要的经验。作为一名积极的管理者，他为公司当前面临的外部经济和治理问题提供了领先视角。此外，凭借起CFO背景，他为董事会带来了财务敏锐。
David E. Meador,served as Vice Chairman and Chief Administrative Officer of DTE Energy, a diversified energy company involved in the development and management of energy-related businesses and services, from 2014 until 2022. In his 25 years at DTE Energy, he served in several executive leadership positions, including Executive Vice President and Chief Financial Officer.With over 40 years of experience in the manufacturing and energy sectors, Mr. Meador is a recognized expert in finance and accounting, business strategy, governance, sustainability, mergers and acquisitions, government and community relations, procurement and information technology.Prior to joining DTE Energy, he served in a variety of financial and accounting positions at Chrysler Corporation for 14 years and was an auditor with Coopers & Lybrand.Mr. Meador previously served on the Boards of Amerisure Mutual Insurance, Landauer, Inc. and Energy Insurance Mutual. Mr. Meador led the creation, and is the current Executive Director, of the Detroit Regional CEO Group. - David E. Meador，2001年起担任DTE能源执行副总裁和CFO。1997-2001年担任DTE能源副总裁和财务总管。DTE能源为密歇根企业和家庭提供安全可靠的电力和天然气服务，其能源相关业务和服务遍及全国。1983-1997年曾担任克莱斯勒汽车公司各种财务和会计职位。他的专业生涯开始于Coopers和Lybrand，并且是一位注册会计师。他担任能源公司高管的经历为核电行业提供了重要的经验。作为一名积极的管理者，他为公司当前面临的外部经济和治理问题提供了领先视角。此外，凭借起CFO背景，他为董事会带来了财务敏锐。
- David E. Meador,served as Vice Chairman and Chief Administrative Officer of DTE Energy, a diversified energy company involved in the development and management of energy-related businesses and services, from 2014 until 2022. In his 25 years at DTE Energy, he served in several executive leadership positions, including Executive Vice President and Chief Financial Officer.With over 40 years of experience in the manufacturing and energy sectors, Mr. Meador is a recognized expert in finance and accounting, business strategy, governance, sustainability, mergers and acquisitions, government and community relations, procurement and information technology.Prior to joining DTE Energy, he served in a variety of financial and accounting positions at Chrysler Corporation for 14 years and was an auditor with Coopers & Lybrand.Mr. Meador previously served on the Boards of Amerisure Mutual Insurance, Landauer, Inc. and Energy Insurance Mutual. Mr. Meador led the creation, and is the current Executive Director, of the Detroit Regional CEO Group.
- Robert J. Cronin
-
Robert J. Cronin ，自2001年以来，在一家为印刷行业提供咨询和投资银行的供应商- The Open Approach 有限责任公司担任经营合伙人。在2005年11月-2006年4月期间，他曾在一个压敏标签和相关系统的供应商- York Label股份有限公司担任董事长兼首席执行官。一直到2000年1月，都担任Wallace Computer Services的董事长兼首席执行官；此前，他曾担任总裁、首席执行官兼董事，现已退休。Wallace Computer Services是一个信息管理产品、服务和决绝方案的供应商。他在两个公司担任董事长和首席执行官的经理，以及在多个复杂组织的战略规划和领导经历，为该公司的事宜和面临的机会带来了宝贵的洞察。他还拥有在各种上市公司的几年的管理职位上的相当多的企业管理经验。他是多个私有企业的董事。
Robert J. Cronin, has been a director since 1997. Since 2001 Mr. Cronin has served as Managing Partner, The Open Approach LLC, a provider of consulting services and investment banking to the printing industry. From November 2005 to April 2006 Mr. Cronin was Chairman and Chief Executive Officer, York Label, Inc., a supplier of pressure-sensitive labels and related systems. Until January 2000 Mr. Cronin was Chairman of the Board and Chief Executive Officer of Wallace Computer Services; previously President, Chief Executive Officer and Director; now retired. Wallace Computer Services is a provider of information management products, services and solutions. Mr. Cronin serves on the Audit and Governance and Nominating Committees and is the Lead Director of the Board of Directors. - Robert J. Cronin ，自2001年以来，在一家为印刷行业提供咨询和投资银行的供应商- The Open Approach 有限责任公司担任经营合伙人。在2005年11月-2006年4月期间，他曾在一个压敏标签和相关系统的供应商- York Label股份有限公司担任董事长兼首席执行官。一直到2000年1月，都担任Wallace Computer Services的董事长兼首席执行官；此前，他曾担任总裁、首席执行官兼董事，现已退休。Wallace Computer Services是一个信息管理产品、服务和决绝方案的供应商。他在两个公司担任董事长和首席执行官的经理，以及在多个复杂组织的战略规划和领导经历，为该公司的事宜和面临的机会带来了宝贵的洞察。他还拥有在各种上市公司的几年的管理职位上的相当多的企业管理经验。他是多个私有企业的董事。
- Robert J. Cronin, has been a director since 1997. Since 2001 Mr. Cronin has served as Managing Partner, The Open Approach LLC, a provider of consulting services and investment banking to the printing industry. From November 2005 to April 2006 Mr. Cronin was Chairman and Chief Executive Officer, York Label, Inc., a supplier of pressure-sensitive labels and related systems. Until January 2000 Mr. Cronin was Chairman of the Board and Chief Executive Officer of Wallace Computer Services; previously President, Chief Executive Officer and Director; now retired. Wallace Computer Services is a provider of information management products, services and solutions. Mr. Cronin serves on the Audit and Governance and Nominating Committees and is the Lead Director of the Board of Directors.
- Michael T. Leatherman
-
Michael T. Leatherman，2011年9月-2011年12月期间，曾在Landauer，Inc担任临时财务总监。自2000年以来，他主要在信息技术行业担任独立顾问。1990-2000年期间，他曾在Wallace Computer Services担任谷中高级领导职位，包括副执行总裁、首席信息官，以及在1998-2000年期间担任财务总监。1984-1990年期间，他曾在Smorgon Consolidated Industries的一个子公司- FSC Paper Corporation担任首席执行官。Leatherman先生是一位注册会计师。作为一名高级主管，他拥有专业信息系统战略和项目完善以及专业的一般操作和战略领导的信息技术知识。另外，他给董事会讨论带来了他作为财务总监的这个背景优势的财务敏感度。2006-2009年期间，他曾是被Cenveo, Inc.收购的公司-Nashua Corporation的董事，以及是一个提供连续关怀退休服务的非营利组织的董事。
Michael T. Leatherman has been a director since 2008. Mr. Leatherman has served as Executive Chairman of the Board since October 2015. From December 2014 through September 2015 Mr. Leatherman served as President and Chief Executive Officer of the Company. From September 2014 through December 2014 Mr. Leatherman was the Company’s Interim President and Chief Executive Officer, and from September 2011 through December 2011 he was Interim Chief Financial Officer of the Company. Mr. Leatherman began his career in public accounting, working with various firms from 1974-1976. In 1977 Mr. Leatherman joined Wallace Business Forms, which later became Wallace Computer Services. In 1984 Mr. Leatherman received a Certified Public Accountant certificate in Illinois, but has not practiced as such. From 1984 to 1990 Mr. Leatherman was Chief Executive Officer of FSC Paper Corporation, a subsidiary of Smorgon Consolidated Industries. From 1990 to 2000 Mr. Leatherman held various senior leadership positions with Wallace Computer Services including Executive Vice President, Chief Information Officer and Chief Financial Officer from 1998 to 2000. From 2000 through December 2014 other than during the period when he served as our Interim Chief Financial Officer, Mr. Leatherman was an independent consultant, primarily to the Information Technology industry. - Michael T. Leatherman，2011年9月-2011年12月期间，曾在Landauer，Inc担任临时财务总监。自2000年以来，他主要在信息技术行业担任独立顾问。1990-2000年期间，他曾在Wallace Computer Services担任谷中高级领导职位，包括副执行总裁、首席信息官，以及在1998-2000年期间担任财务总监。1984-1990年期间，他曾在Smorgon Consolidated Industries的一个子公司- FSC Paper Corporation担任首席执行官。Leatherman先生是一位注册会计师。作为一名高级主管，他拥有专业信息系统战略和项目完善以及专业的一般操作和战略领导的信息技术知识。另外，他给董事会讨论带来了他作为财务总监的这个背景优势的财务敏感度。2006-2009年期间，他曾是被Cenveo, Inc.收购的公司-Nashua Corporation的董事，以及是一个提供连续关怀退休服务的非营利组织的董事。
- Michael T. Leatherman has been a director since 2008. Mr. Leatherman has served as Executive Chairman of the Board since October 2015. From December 2014 through September 2015 Mr. Leatherman served as President and Chief Executive Officer of the Company. From September 2014 through December 2014 Mr. Leatherman was the Company’s Interim President and Chief Executive Officer, and from September 2011 through December 2011 he was Interim Chief Financial Officer of the Company. Mr. Leatherman began his career in public accounting, working with various firms from 1974-1976. In 1977 Mr. Leatherman joined Wallace Business Forms, which later became Wallace Computer Services. In 1984 Mr. Leatherman received a Certified Public Accountant certificate in Illinois, but has not practiced as such. From 1984 to 1990 Mr. Leatherman was Chief Executive Officer of FSC Paper Corporation, a subsidiary of Smorgon Consolidated Industries. From 1990 to 2000 Mr. Leatherman held various senior leadership positions with Wallace Computer Services including Executive Vice President, Chief Information Officer and Chief Financial Officer from 1998 to 2000. From 2000 through December 2014 other than during the period when he served as our Interim Chief Financial Officer, Mr. Leatherman was an independent consultant, primarily to the Information Technology industry.
- Stephen C. Mitchell
-
Stephen C. Mitchell，自2001年以来，在一家为新合资公司的创立和管理提供服务的私有企业- Knight Group有限责任公司的总裁。自1995年以来，他是一家为全球工业和商业客户提供设备和管理服务外包的公司- Knight Facilities Management, Inc.的副董事长兼董事。1975年-2001年，他在一家从事先进技术研究、开发以及生产设备的计划、设计和建设的公司- Lester B. Knight & Associates股份有限公司的总裁、首席运营官以及董事。他有各种行业和各种规模公司运营和战略领导的领导经验。他还有相当多的在其他上市公司董事会的多年的企业管理经验。他是一家为建筑和艺术品装裱行业玻璃产品的制造商- Apogee Enterprises股份有限公司的董事。
Stephen C. Mitchell has been a director since 2005. Since 2001 Mr. Mitchell has served as President, Knight Group, LLC, a privately-held firm providing services for the start-up and management of new ventures. Since 1995 Mr. Mitchell has served as Vice Chairman and Director, Knight Facilities Management, Inc., a company providing outsourcing of facilities management services for industrial and commercial clients worldwide. Until 2001 Mr. Mitchell was President, Chief Operating Officer and Director, Lester B. Knight & Associates, Inc. a company involved in the planning, design and construction of advanced technology research and development and manufacturing facilities. Mr. Mitchell served as the Chair of the City of Chicago's Mayor's Council of Technology Advisers and Chair of The Illinois Coalition, both of which focused on the development needs of the City of Chicago and State of Illinois, as well as technology-based enterprise development. Mr. Mitchell serves on the Compensation Committee and is Chairman of the Governance and Nominating Committee. - Stephen C. Mitchell，自2001年以来，在一家为新合资公司的创立和管理提供服务的私有企业- Knight Group有限责任公司的总裁。自1995年以来，他是一家为全球工业和商业客户提供设备和管理服务外包的公司- Knight Facilities Management, Inc.的副董事长兼董事。1975年-2001年，他在一家从事先进技术研究、开发以及生产设备的计划、设计和建设的公司- Lester B. Knight & Associates股份有限公司的总裁、首席运营官以及董事。他有各种行业和各种规模公司运营和战略领导的领导经验。他还有相当多的在其他上市公司董事会的多年的企业管理经验。他是一家为建筑和艺术品装裱行业玻璃产品的制造商- Apogee Enterprises股份有限公司的董事。
- Stephen C. Mitchell has been a director since 2005. Since 2001 Mr. Mitchell has served as President, Knight Group, LLC, a privately-held firm providing services for the start-up and management of new ventures. Since 1995 Mr. Mitchell has served as Vice Chairman and Director, Knight Facilities Management, Inc., a company providing outsourcing of facilities management services for industrial and commercial clients worldwide. Until 2001 Mr. Mitchell was President, Chief Operating Officer and Director, Lester B. Knight & Associates, Inc. a company involved in the planning, design and construction of advanced technology research and development and manufacturing facilities. Mr. Mitchell served as the Chair of the City of Chicago's Mayor's Council of Technology Advisers and Chair of The Illinois Coalition, both of which focused on the development needs of the City of Chicago and State of Illinois, as well as technology-based enterprise development. Mr. Mitchell serves on the Compensation Committee and is Chairman of the Governance and Nominating Committee.
- Thomas M. White
-
Thomas M. White，自2007年以来，是一家私人股本公司- Apollo Management L.P。的运营合伙人。目前在荷兰（Netherlands）一个Apollo公司拥有的、提供合约物流、货运代理和供应链管理服务的公司- CEVA Logistics担任临时的首席运营官。在2011-2012年期间，他曾在法国（France）一家Apollo公司拥有的、生产铝制品的公司- Constellium的财务总监；在2009-2010年期间，曾在加拿大（Canada）一个Apollo公司拥有的、提供包机物流服务的公司- SkyLink Aviation股份有限公司担任财务总监；在2002-2007年期间在一家纳斯达克（NASDAQ）上市的、提供物流服务的公司- Hub Group股份有限公司担任财务总监。在加入Hub Group之前，他曾是其于1979年加入的Arthur Andersen公司的审计合伙人。White先生是一位注册会计师。他拥有在全球公司担任高级主管和财务总监的丰富的全球运营、财务、国际业务和战略规划知识。另外，拥有作为财务总监的背景优势，他给董事会讨论会带来了高度的财务敏感度。他是CEVA Group, PLC的董事、一家纳斯达克（NASDAQ）上市的公司- Quality Distribution股份有限公司的董事、一家在纳斯达克（NASDAQ）上市的公司- EVERTEC股份有限公司的董事、一家纽约证券交易所（NYSE）上市的公司- FTD股份有限公司以及SkyLink Aviation股份有限公司的董事。
Thomas M. White,From 2015 to 2019 Mr. White was the Executive Chairman of Cardinal Logistics Holdings, LLC, a dedicated transportation and logistics services provider. From 2007 until 2014 Mr. White served as an Operating Partner for Apollo Global Management L.P., an alternative asset management firm, serving in a variety of interim operating roles COO and CFO and board of director positions for its portfolio companies. From 2002 to 2007 Mr. White served as Chief Financial Officer of Hub Group, Inc., a NASDAQ listed company which provides logistics services. Prior to joining Hub Group, Mr. White was an audit partner with Arthur Andersen, which he joined in 1979. Currently Mr. White sits on the privately held board of JPW Holdings GP LLC, a wholesale distributor of machine tools and equipment. Previously Mr. White served on the board of Reddy Ice Holdings, Inc., and also served on the then publicly held boards of Landauer, Inc. (NYSE), FTD Group, Inc. (NASDAQ) and Quality Distribution, Inc. (NASDAQ) in a variety of roles including board chairman and committee chairman of the audit and compensation committees. In addition, he served on the audit committees of the then privately held boards of CEVA Logistics, plc (now listed on the SIX Swiss Exchange) and EVERTEC, Inc. (now listed on the NYSE). Mr. White is a non-practicing Certified Public Accountant. Mr. White was elected chairman of the Company’s board of directors in December 2019. - Thomas M. White，自2007年以来，是一家私人股本公司- Apollo Management L.P。的运营合伙人。目前在荷兰（Netherlands）一个Apollo公司拥有的、提供合约物流、货运代理和供应链管理服务的公司- CEVA Logistics担任临时的首席运营官。在2011-2012年期间，他曾在法国（France）一家Apollo公司拥有的、生产铝制品的公司- Constellium的财务总监；在2009-2010年期间，曾在加拿大（Canada）一个Apollo公司拥有的、提供包机物流服务的公司- SkyLink Aviation股份有限公司担任财务总监；在2002-2007年期间在一家纳斯达克（NASDAQ）上市的、提供物流服务的公司- Hub Group股份有限公司担任财务总监。在加入Hub Group之前，他曾是其于1979年加入的Arthur Andersen公司的审计合伙人。White先生是一位注册会计师。他拥有在全球公司担任高级主管和财务总监的丰富的全球运营、财务、国际业务和战略规划知识。另外，拥有作为财务总监的背景优势，他给董事会讨论会带来了高度的财务敏感度。他是CEVA Group, PLC的董事、一家纳斯达克（NASDAQ）上市的公司- Quality Distribution股份有限公司的董事、一家在纳斯达克（NASDAQ）上市的公司- EVERTEC股份有限公司的董事、一家纽约证券交易所（NYSE）上市的公司- FTD股份有限公司以及SkyLink Aviation股份有限公司的董事。
- Thomas M. White,From 2015 to 2019 Mr. White was the Executive Chairman of Cardinal Logistics Holdings, LLC, a dedicated transportation and logistics services provider. From 2007 until 2014 Mr. White served as an Operating Partner for Apollo Global Management L.P., an alternative asset management firm, serving in a variety of interim operating roles COO and CFO and board of director positions for its portfolio companies. From 2002 to 2007 Mr. White served as Chief Financial Officer of Hub Group, Inc., a NASDAQ listed company which provides logistics services. Prior to joining Hub Group, Mr. White was an audit partner with Arthur Andersen, which he joined in 1979. Currently Mr. White sits on the privately held board of JPW Holdings GP LLC, a wholesale distributor of machine tools and equipment. Previously Mr. White served on the board of Reddy Ice Holdings, Inc., and also served on the then publicly held boards of Landauer, Inc. (NYSE), FTD Group, Inc. (NASDAQ) and Quality Distribution, Inc. (NASDAQ) in a variety of roles including board chairman and committee chairman of the audit and compensation committees. In addition, he served on the audit committees of the then privately held boards of CEVA Logistics, plc (now listed on the SIX Swiss Exchange) and EVERTEC, Inc. (now listed on the NYSE). Mr. White is a non-practicing Certified Public Accountant. Mr. White was elected chairman of the Company’s board of directors in December 2019.
高管简历
中英对照 | 中文 | 英文- Daniel J. Fujii
Daniel J. Fujii，他曾担任公司的副总裁、首席财务官兼秘书，以及其首席财务官（2015年4月以来）。此前，他曾担任公司的副总裁、公司总会计师和首席会计官（自2014年4月以来）。从2012年1月到2014年3月，他曾担任Actient Pharmaceuticals, LLC（一个私人专业制药公司，被Auxilium Pharmaceuticals, Inc收购）的公司总会计师。从2007年10月到2012年1月，他曾担任Nanosphere, Inc.（医疗诊断设备的制造商）的财务主管兼总会计师。他曾担任一些其它上市组织的财务领导职务，其中包括Richardson Electronics, Ltd（设计解决方案的供应商、电子设备市场的电子元件的经销商）。他的职业生涯始于任职PricewaterhouseCoopers LLP。他是注册会计师，并持有the University of Illinois的会计学士学位。
Daniel J. Fujii has served as the Company’s Vice President, Chief Financial Officer and Secretary, as well as its principal financial officer, since April 2015. Prior to this appointment, Mr. Fujii served as Vice President, Corporate Controller and Chief Accounting Officer of the Company since April 2014. From January 2012 to March 2014 he was corporate controller of Actient Pharmaceuticals, LLC, a private specialty pharmaceuticals company that was acquired by Auxilium Pharmaceuticals, Inc. From October 2007 to January 2012 he was director of finance and controller for Nanosphere, Inc., a manufacturer of medical diagnostic equipment. Mr. Fujii’s experience also includes a financial leadership position at a publicly held organization, Richardson Electronics, Ltd., a provider of engineered solutions and distributor of electronic components to the electron device marketplace, and he began his career at PricewaterhouseCoopers LLP. He is a Certified Public Accountant and earned a Bachelor of Science in accounting from the University of Illinois.- Daniel J. Fujii，他曾担任公司的副总裁、首席财务官兼秘书，以及其首席财务官（2015年4月以来）。此前，他曾担任公司的副总裁、公司总会计师和首席会计官（自2014年4月以来）。从2012年1月到2014年3月，他曾担任Actient Pharmaceuticals, LLC（一个私人专业制药公司，被Auxilium Pharmaceuticals, Inc收购）的公司总会计师。从2007年10月到2012年1月，他曾担任Nanosphere, Inc.（医疗诊断设备的制造商）的财务主管兼总会计师。他曾担任一些其它上市组织的财务领导职务，其中包括Richardson Electronics, Ltd（设计解决方案的供应商、电子设备市场的电子元件的经销商）。他的职业生涯始于任职PricewaterhouseCoopers LLP。他是注册会计师，并持有the University of Illinois的会计学士学位。
- Daniel J. Fujii has served as the Company’s Vice President, Chief Financial Officer and Secretary, as well as its principal financial officer, since April 2015. Prior to this appointment, Mr. Fujii served as Vice President, Corporate Controller and Chief Accounting Officer of the Company since April 2014. From January 2012 to March 2014 he was corporate controller of Actient Pharmaceuticals, LLC, a private specialty pharmaceuticals company that was acquired by Auxilium Pharmaceuticals, Inc. From October 2007 to January 2012 he was director of finance and controller for Nanosphere, Inc., a manufacturer of medical diagnostic equipment. Mr. Fujii’s experience also includes a financial leadership position at a publicly held organization, Richardson Electronics, Ltd., a provider of engineered solutions and distributor of electronic components to the electron device marketplace, and he began his career at PricewaterhouseCoopers LLP. He is a Certified Public Accountant and earned a Bachelor of Science in accounting from the University of Illinois.
- G. Douglas King
G. Douglas King，2015年4月以来，他一直担任高级行政副总裁、首席信息官。他是公司的副总裁兼首席信息官（2009年4月以来）。他拥有任职财富500强和较小的私人制造业和工业公司的20年以上的经验。任职Landauer公司之前，他曾担任多种运营领导职务，包括高级副总裁兼首席信息官、负责销售和营销的高级副总裁、公司运营副总裁、供应链管理董事、项目办公室董事。他持有the J.L.Kellogg Graduate School of Management at Northwestern University的工商管理学硕士和工程管理硕士学位（双硕士学位），在那里他专注于管理和战略、信息技术和生产管理。他也持有Northwestern University的学士学位。
G. Douglas King has served as Senior Vice President, Administration and Chief Information Officer since April 2015. He was Vice President and Chief Information Officer of the Company since April 2009. Mr. King has over 25 years of experience in both Fortune 500 and smaller private manufacturing and industrial companies. Prior to Landauer, Mr. King held several Operations leadership roles, including Senior VP and Chief Information Officer of a $1B North American Engineered Construction Products Manufacturer, Senior VP of Sales and Marketing, Corporate Vice President of Operations, Director of Supply Chain Management, and Program Office Director. Mr. King earned a dual Masters Degree MBA, MEM from the J.L. Kellogg Graduate School of Management at Northwestern University, where he graduated with concentrations in Management & Strategy, Information Technology and Manufacturing Management. He also earned his Bachelor of Arts at Northwestern University.- G. Douglas King，2015年4月以来，他一直担任高级行政副总裁、首席信息官。他是公司的副总裁兼首席信息官（2009年4月以来）。他拥有任职财富500强和较小的私人制造业和工业公司的20年以上的经验。任职Landauer公司之前，他曾担任多种运营领导职务，包括高级副总裁兼首席信息官、负责销售和营销的高级副总裁、公司运营副总裁、供应链管理董事、项目办公室董事。他持有the J.L.Kellogg Graduate School of Management at Northwestern University的工商管理学硕士和工程管理硕士学位（双硕士学位），在那里他专注于管理和战略、信息技术和生产管理。他也持有Northwestern University的学士学位。
- G. Douglas King has served as Senior Vice President, Administration and Chief Information Officer since April 2015. He was Vice President and Chief Information Officer of the Company since April 2009. Mr. King has over 25 years of experience in both Fortune 500 and smaller private manufacturing and industrial companies. Prior to Landauer, Mr. King held several Operations leadership roles, including Senior VP and Chief Information Officer of a $1B North American Engineered Construction Products Manufacturer, Senior VP of Sales and Marketing, Corporate Vice President of Operations, Director of Supply Chain Management, and Program Office Director. Mr. King earned a dual Masters Degree MBA, MEM from the J.L. Kellogg Graduate School of Management at Northwestern University, where he graduated with concentrations in Management & Strategy, Information Technology and Manufacturing Management. He also earned his Bachelor of Arts at Northwestern University.
- Michael P. Kaminski
Michael P. Kaminski被任命为首席执行官，于2009年1月1日生效，并仍然持有总裁的头衔，之前自2007年2月以来担任我们的总裁兼首席运营官。他之前担任我们的首席运营官（自2002年4月他加入公司以来）。在加入公司之前，他在Hill-Rom Company Hillenbrand Industries工作近20年。在Hill-Rom担任的最后职位是北美销售和服务的高级副总裁。在此之前，他担任Hill-Rom急症护理医院部门的总经理。他获得泽维尔大学（Xavier University）的工商管理硕士学位，印第安纳大学（Indiana University）市场营销学士学位。作为我们的首席执行官，他在范围广泛的问题上（包括战略规划、项目实施、营销以及投资者关系和金融社区）向董事会提供了全面的洞察力。他告知董事会，他将从公司辞职，于2013年4月12日生效。
Michael P. Kaminski has been the Company’s President and Chief Executive Officer, and a member of the Board of Directors, since October 2015. Mr. Kaminski joined the Company in April 2013 as President, Radiation Measurement. He was President and Chief Executive Officer of Stereotaxis, Inc., a healthcare technology company specializing in the development of robotic cardiology instrument navigation systems, since 2009 and held other senior positions there since 2002. Prior to joining Stereotaxis, Mr. Kaminski spent nearly 20 years with Hill-Rom Company Hillenbrand Industries, where he held several senior level positions. Mr. Kaminski earned a Bachelor of Science in marketing from Indiana University and an MBA from Xavier University.- Michael P. Kaminski被任命为首席执行官，于2009年1月1日生效，并仍然持有总裁的头衔，之前自2007年2月以来担任我们的总裁兼首席运营官。他之前担任我们的首席运营官（自2002年4月他加入公司以来）。在加入公司之前，他在Hill-Rom Company Hillenbrand Industries工作近20年。在Hill-Rom担任的最后职位是北美销售和服务的高级副总裁。在此之前，他担任Hill-Rom急症护理医院部门的总经理。他获得泽维尔大学（Xavier University）的工商管理硕士学位，印第安纳大学（Indiana University）市场营销学士学位。作为我们的首席执行官，他在范围广泛的问题上（包括战略规划、项目实施、营销以及投资者关系和金融社区）向董事会提供了全面的洞察力。他告知董事会，他将从公司辞职，于2013年4月12日生效。
- Michael P. Kaminski has been the Company’s President and Chief Executive Officer, and a member of the Board of Directors, since October 2015. Mr. Kaminski joined the Company in April 2013 as President, Radiation Measurement. He was President and Chief Executive Officer of Stereotaxis, Inc., a healthcare technology company specializing in the development of robotic cardiology instrument navigation systems, since 2009 and held other senior positions there since 2002. Prior to joining Stereotaxis, Mr. Kaminski spent nearly 20 years with Hill-Rom Company Hillenbrand Industries, where he held several senior level positions. Mr. Kaminski earned a Bachelor of Science in marketing from Indiana University and an MBA from Xavier University.
- Michael T. Leatherman
Michael T. Leatherman，2011年9月-2011年12月期间，曾在Landauer，Inc担任临时财务总监。自2000年以来，他主要在信息技术行业担任独立顾问。1990-2000年期间，他曾在Wallace Computer Services担任谷中高级领导职位，包括副执行总裁、首席信息官，以及在1998-2000年期间担任财务总监。1984-1990年期间，他曾在Smorgon Consolidated Industries的一个子公司- FSC Paper Corporation担任首席执行官。Leatherman先生是一位注册会计师。作为一名高级主管，他拥有专业信息系统战略和项目完善以及专业的一般操作和战略领导的信息技术知识。另外，他给董事会讨论带来了他作为财务总监的这个背景优势的财务敏感度。2006-2009年期间，他曾是被Cenveo, Inc.收购的公司-Nashua Corporation的董事，以及是一个提供连续关怀退休服务的非营利组织的董事。
Michael T. Leatherman has been a director since 2008. Mr. Leatherman has served as Executive Chairman of the Board since October 2015. From December 2014 through September 2015 Mr. Leatherman served as President and Chief Executive Officer of the Company. From September 2014 through December 2014 Mr. Leatherman was the Company’s Interim President and Chief Executive Officer, and from September 2011 through December 2011 he was Interim Chief Financial Officer of the Company. Mr. Leatherman began his career in public accounting, working with various firms from 1974-1976. In 1977 Mr. Leatherman joined Wallace Business Forms, which later became Wallace Computer Services. In 1984 Mr. Leatherman received a Certified Public Accountant certificate in Illinois, but has not practiced as such. From 1984 to 1990 Mr. Leatherman was Chief Executive Officer of FSC Paper Corporation, a subsidiary of Smorgon Consolidated Industries. From 1990 to 2000 Mr. Leatherman held various senior leadership positions with Wallace Computer Services including Executive Vice President, Chief Information Officer and Chief Financial Officer from 1998 to 2000. From 2000 through December 2014 other than during the period when he served as our Interim Chief Financial Officer, Mr. Leatherman was an independent consultant, primarily to the Information Technology industry.- Michael T. Leatherman，2011年9月-2011年12月期间，曾在Landauer，Inc担任临时财务总监。自2000年以来，他主要在信息技术行业担任独立顾问。1990-2000年期间，他曾在Wallace Computer Services担任谷中高级领导职位，包括副执行总裁、首席信息官，以及在1998-2000年期间担任财务总监。1984-1990年期间，他曾在Smorgon Consolidated Industries的一个子公司- FSC Paper Corporation担任首席执行官。Leatherman先生是一位注册会计师。作为一名高级主管，他拥有专业信息系统战略和项目完善以及专业的一般操作和战略领导的信息技术知识。另外，他给董事会讨论带来了他作为财务总监的这个背景优势的财务敏感度。2006-2009年期间，他曾是被Cenveo, Inc.收购的公司-Nashua Corporation的董事，以及是一个提供连续关怀退休服务的非营利组织的董事。
- Michael T. Leatherman has been a director since 2008. Mr. Leatherman has served as Executive Chairman of the Board since October 2015. From December 2014 through September 2015 Mr. Leatherman served as President and Chief Executive Officer of the Company. From September 2014 through December 2014 Mr. Leatherman was the Company’s Interim President and Chief Executive Officer, and from September 2011 through December 2011 he was Interim Chief Financial Officer of the Company. Mr. Leatherman began his career in public accounting, working with various firms from 1974-1976. In 1977 Mr. Leatherman joined Wallace Business Forms, which later became Wallace Computer Services. In 1984 Mr. Leatherman received a Certified Public Accountant certificate in Illinois, but has not practiced as such. From 1984 to 1990 Mr. Leatherman was Chief Executive Officer of FSC Paper Corporation, a subsidiary of Smorgon Consolidated Industries. From 1990 to 2000 Mr. Leatherman held various senior leadership positions with Wallace Computer Services including Executive Vice President, Chief Information Officer and Chief Financial Officer from 1998 to 2000. From 2000 through December 2014 other than during the period when he served as our Interim Chief Financial Officer, Mr. Leatherman was an independent consultant, primarily to the Information Technology industry.
- William G. Dempsey
William G. Dempsey从1982年到2007年，在Abbott Laboratories担任过多个行政职务，包括从2006年开始担任全球制药公司的执行副总裁，从2003年开始担任制药业务部高级副总裁，从1999年开始担任国际业务部高级副总裁。他曾担任美国PhRMA药物研究和制造商国际组主席和加速获取倡议主席，该倡议是联合国艾滋病规划署、世界银行和六家以研究为基础的制药公司的公私合作伙伴关系。Dempsey拥有德保罗大学会计学学士学位。Dempsey目前担任Hill-Rom控股公司董事会非执行主席，担任并购委员会主席和提名和治理委员会成员。过去五年，Dempsey先生在Landauer, Inc.董事会任职。2018年3月至2018年7月，Dempsey先生担任Hill-Rom Holdings，Inc.的执行主席。Dempsey是佛罗里达州Immokalee的Guadalupe中心董事会成员。
William G. Dempsey held various executive positions with Abbott Laboratories from 1982 until 2007 including Executive Vice President of Global Pharmaceuticals from 2006 Senior Vice President of Pharmaceutical Operations from 2003 and Senior Vice President of International Operations from 1999. He has previously served as Chairman of the International Section of the Pharmaceutical Research and Manufacturers of America PhRMA and as Chairman of the Accelerating Access Initiative, a cooperative public-private partnership of UNAIDS, the World Bank, and six research-based pharmaceutical companies.Mr. Dempsey holds a Bachelor of Science degree in accounting from DePaul University.Mr. Dempsey currently serves as non-executive Chairman of the Board of Hill-Rom Holdings, Inc., where he is Chair of the Mergers and Acquisitions Committee and a member of the Nominating and Governance Committee. In the past five years, Mr. Dempsey has served on the board of Landauer, Inc. From March 2018 to July 2018 Mr. Dempsey served as Executive Chairman of Hill-Rom Holdings, Inc.Mr. Dempsey is a member of the Board of Trustees for the Guadalupe Center in Immokalee Florida.- William G. Dempsey从1982年到2007年，在Abbott Laboratories担任过多个行政职务，包括从2006年开始担任全球制药公司的执行副总裁，从2003年开始担任制药业务部高级副总裁，从1999年开始担任国际业务部高级副总裁。他曾担任美国PhRMA药物研究和制造商国际组主席和加速获取倡议主席，该倡议是联合国艾滋病规划署、世界银行和六家以研究为基础的制药公司的公私合作伙伴关系。Dempsey拥有德保罗大学会计学学士学位。Dempsey目前担任Hill-Rom控股公司董事会非执行主席，担任并购委员会主席和提名和治理委员会成员。过去五年，Dempsey先生在Landauer, Inc.董事会任职。2018年3月至2018年7月，Dempsey先生担任Hill-Rom Holdings，Inc.的执行主席。Dempsey是佛罗里达州Immokalee的Guadalupe中心董事会成员。
- William G. Dempsey held various executive positions with Abbott Laboratories from 1982 until 2007 including Executive Vice President of Global Pharmaceuticals from 2006 Senior Vice President of Pharmaceutical Operations from 2003 and Senior Vice President of International Operations from 1999. He has previously served as Chairman of the International Section of the Pharmaceutical Research and Manufacturers of America PhRMA and as Chairman of the Accelerating Access Initiative, a cooperative public-private partnership of UNAIDS, the World Bank, and six research-based pharmaceutical companies.Mr. Dempsey holds a Bachelor of Science degree in accounting from DePaul University.Mr. Dempsey currently serves as non-executive Chairman of the Board of Hill-Rom Holdings, Inc., where he is Chair of the Mergers and Acquisitions Committee and a member of the Nominating and Governance Committee. In the past five years, Mr. Dempsey has served on the board of Landauer, Inc. From March 2018 to July 2018 Mr. Dempsey served as Executive Chairman of Hill-Rom Holdings, Inc.Mr. Dempsey is a member of the Board of Trustees for the Guadalupe Center in Immokalee Florida.
- Michael R. Kennedy
Michael R. Kennedy，自2011年8月以来一直在Landauer Inc.的子公司- Landauer Medical Physics担任总裁，以及在Landauer Inc.担任全球营销副总裁。Kennedy先生拥有超过25年的在财务500和小型私有医疗公司的医疗科技创新和商业领导经验。在加入Landauer之前，他曾在Baxter Healthcare、GE以及多个私有医疗公司担任战略营销、运营、产品开发和总务管理的高级管理职务。在这些职位上，他曾领导了透析法、血液成分疗法、吸入药剂传送、以及影像诊断生命周期管理服务等一些重要的医疗设备创新和商业转换。他是在Washington大学获得化学工程学士学位，以及在Northwestern大学J.L. Kellogg研究生商学院获得工商管理学硕士学位的。
Michael R. Kennedy has served as Senior Vice President, Strategic Marketing and Product Development since April 2015. He was President of Landauer Medical Physics, a subsidiary of Landauer Inc., and Vice President Global Marketing for Landauer Inc. from August 2011 through April 2015. Mr. Kennedy has over 25 years of healthcare technology innovation and commercial leadership experience in both Fortune 500 and smaller private healthcare companies. Prior to joining Landauer, he held executive positions in strategic marketing, operations, product development, and general management at Baxter Healthcare, GE, and private healthcare companies. In these roles, he led significant medical device innovations and business transformations in dialysis, blood component therapy, inhaled drug delivery, and diagnostic imaging lifecycle management services. Mr. Kennedy earned a Bachelor of Science in chemical engineering from the University of Washington and an MBA from J.L. Kellogg Graduate School of Management at Northwestern University.- Michael R. Kennedy，自2011年8月以来一直在Landauer Inc.的子公司- Landauer Medical Physics担任总裁，以及在Landauer Inc.担任全球营销副总裁。Kennedy先生拥有超过25年的在财务500和小型私有医疗公司的医疗科技创新和商业领导经验。在加入Landauer之前，他曾在Baxter Healthcare、GE以及多个私有医疗公司担任战略营销、运营、产品开发和总务管理的高级管理职务。在这些职位上，他曾领导了透析法、血液成分疗法、吸入药剂传送、以及影像诊断生命周期管理服务等一些重要的医疗设备创新和商业转换。他是在Washington大学获得化学工程学士学位，以及在Northwestern大学J.L. Kellogg研究生商学院获得工商管理学硕士学位的。
- Michael R. Kennedy has served as Senior Vice President, Strategic Marketing and Product Development since April 2015. He was President of Landauer Medical Physics, a subsidiary of Landauer Inc., and Vice President Global Marketing for Landauer Inc. from August 2011 through April 2015. Mr. Kennedy has over 25 years of healthcare technology innovation and commercial leadership experience in both Fortune 500 and smaller private healthcare companies. Prior to joining Landauer, he held executive positions in strategic marketing, operations, product development, and general management at Baxter Healthcare, GE, and private healthcare companies. In these roles, he led significant medical device innovations and business transformations in dialysis, blood component therapy, inhaled drug delivery, and diagnostic imaging lifecycle management services. Mr. Kennedy earned a Bachelor of Science in chemical engineering from the University of Washington and an MBA from J.L. Kellogg Graduate School of Management at Northwestern University.